Roundtable on Black in cancer research and oncology - presented by Dr. Brandon Blue MD and Dr. Kilan Ashad-Bishop and Drs. Onyinye and Folu Balogun and Runcie C.W. Chidebe Dip., BSc., MSc., and Kathryn Mcginnis and Dr Paraskevi Mallini and Dr. Lisa Hoffmann-Haas

Roundtable on Black in cancer research and oncology

Brandon Blue, Kilan Ashad-Bishop, Onyinye and Folu Balogun and Runcie C.W. Chidebe

Dr. Brandon Blue MDDr. Kilan Ashad-BishopDrs. Onyinye and Folu BalogunRuncie C.W. Chidebe Dip., BSc., MSc.,
Slide at 05:05
T cell activation requires 2 signals Dr. Brandon Blue MHC-Ag CD28 T cell Signal 1 Signal 2 Activation Co-stimulation IL-2 production Cytoskeletal reorganization Sadelain et al. Nat Rev Cancer 2003
1
References
  • 1.
    M. Sadelain et al. (2003) Targeting tumours with genetically enhanced T lymphocytes. Nature Reviews Cancer
Share slide
Summary (AI generated)

In this particular case, we are utilizing the same mechanism but with a different approach when it comes to cancer. It is important to understand that the co-stimulatory domain has shown promising outcomes across various types of cancer.